Florian Sänger
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Florian Sänger has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
- René Dörfelt
Ludwig-Maximilians-Universität Small Animal Clinic, Centre for Clinical Veterinary Medicine, Faculty of Veterinary Medicine, Ludwig-Maximilians-Universität München, Munich, Germany
7 shared publications Katrin Hartmann
Department für Klinische Veterinärmedizin, Kleintierklinik, Ludwig-Maximilians-Universität München
3 shared publicationsRené Dörfelt
LMU Small Animal Clinic, Centre for Clinical Veterinary Medicine, Faculty of Veterinary Medicine, Ludwig-Maximilians-Universität München, Germany
3 shared publications- Katrin Hartmann
LMU Small Animal Clinic, Centre for Clinical Veterinary Medicine, LMU Munich, Germany
2 shared publications Saskia Herges
LMU Small Animal Clinic, Centre for Clinical Veterinary Medicine, Faculty of Veterinary Medicine, Ludwig-Maximilians-Universität München, Germany
2 shared publications- Saskia Herges
Ludwig-Maximilians-Universität Small Animal Clinic, Centre for Clinical Veterinary Medicine, Faculty of Veterinary Medicine, Ludwig-Maximilians-Universität München, Munich, Germany
2 shared publications
Latest Publications
- Open Access
- 24 September 2026
- Published by American Veterinary Medical Association (AVMA) in American Journal of Veterinary Research
- p. 1-8
Hemoadsorption with the Cytosorb adsorber can effectively reduce cell-free hemoglobin from porcine blood in vitro
Objective: The aim of this study was to investigate the maximum capacity of the Cytosorb adsorber for clearance of cell-free hemoglobin (cfHb) in a porcine cfHb solution in vitro. Methods: Anticoagulated porcine blood was centrifuged to separate plasma from RBCs. Red blood cell concentrate was stored in the freezer, thawed, and mixed with distilled water to achieve complete hemolysis. The cfHb solution was divided into 12 aliquots of 1,000 mL each. Six test runs were performed in a circular setup with the Cytosorb adsorber. Samples were collected before and after adsorber. After 20 L of processed cfHb solution, the storage bottle was exchanged, and a new storage bottle with 1,000 mL of the cfHb solution with the initial cfHb concentration was processed for another 10 L. Results: The initial median cfHb concentration of the porcine cfHb solution of 4.13 mmol/L (4.03 to 4.22 mmol/L) decreased to 2.70 mmol/L (2.54 to 2.79 mmol/L) after processing 20 L of cfHb solution. This corresponds to a median cfHb reduction of 22.1 g (21.9 to 27.1 g), which was primarily achieved during the first 10.0 L of processed cfHb solution. In the second storage bottle, no further relevant cfHb concentration decrease was achieved. Conclusions: Hemoadsorption using the Cytosorb adsorber effectively reduced cfHb concentration from a porcine cfHb solution in vitro. The maximum adsorption capacity of the Cytosorb adsorber for this experimental setup was about 22.1 g. Clinical Relevance: The Cytosorb adsorber might be a promising tool for removal of cfHb from the circulation in vivo.
- 24 September 2026
- Published by American Veterinary Medical Association (AVMA) in American Journal of Veterinary Research
- p. 1-8
Open AccessHemoadsorption with the Cytosorb adsorber can effectively reduce cell-free hemoglobin from porcine blood in vitro
Objective: The aim of this study was to investigate the maximum capacity of the Cytosorb adsorber for clearance of cell-free hemoglobin (cfHb) in a porcine cfHb solution in vitro. Methods: Anticoagulated porcine blood was centrifuged to separate plasma from RBCs. Red blood cell concentrate was stored in the freezer, thawed, and mixed with distilled water to achieve complete hemolysis. The cfHb solution was divided into 12 aliquots of 1,000 mL each. Six test runs were performed in a circular setup with the Cytosorb adsorber. Samples were collected before and after adsorber. After 20 L of processed cfHb solution, the storage bottle was exchanged, and a new storage bottle with 1,000 mL of the cfHb solution with the initial cfHb concentration was processed for another 10 L. Results: The initial median cfHb concentration of the porcine cfHb solution of 4.13 mmol/L (4.03 to 4.22 mmol/L) decreased to 2.70 mmol/L (2.54 to 2.79 mmol/L) after processing 20 L of cfHb solution. This corresponds to a median cfHb reduction of 22.1 g (21.9 to 27.1 g), which was primarily achieved during the first 10.0 L of processed cfHb solution. In the second storage bottle, no further relevant cfHb concentration decrease was achieved. Conclusions: Hemoadsorption using the Cytosorb adsorber effectively reduced cfHb concentration from a porcine cfHb solution in vitro. The maximum adsorption capacity of the Cytosorb adsorber for this experimental setup was about 22.1 g. Clinical Relevance: The Cytosorb adsorber might be a promising tool for removal of cfHb from the circulation in vivo.
- Open Access
- 1 June 2026
- Published by American Veterinary Medical Association (AVMA) in American Journal of Veterinary Research
- Vol. 87 (6)
Hematological changes after intermittent hemodialysis in dogs with acute kidney injury are mild and transient
Objective: To evaluate hematological changes in dogs with acute kidney injury caused by different underlying disease processes treated with intermittent hemodialysis (IHD) over 12 to 24 hours after the session. Methods: Client-owned dogs with acute kidney injury treated with IHD from February 2021 through July 2025 were prospectively enrolled in this observational study. Blood was collected from each dog before IHD (T0), after IHD (T1), and 12 to 24 hours after IHD (T2). Hematocrit, RBC count, hemoglobin concentration, reticulocyte count, platelet count, and WBC count were evaluated at all time points. Results: In total, 30 dogs with 82 IHD sessions were included in the study. Median RBC count (X 10 12 /L) and median hemoglobin concentration (mmol/L) decreased from 4.00 (2.82 to 7.22) and 9.25 (6.60 to 17.20) at T0 to 3.74 (2.39 to 7.04) and 9.00 (5.50 to 16.80) at T1, respectively. Median WBC count (X 10 9 /L) of 19.34 (6.49 to 55.47) at T0 decreased to 17.6 (4.57 to 73.22) at T1 and increased to 20.11 (7.48 to 55.47) at T2. Median platelet count (X 10 9 /L) of 99 (5 to 767) at T0 decreased to 69 (1 to 633) at T1 and increased to 84 (4 to 604) at T2. Conclusions: Hematological changes during IHD were mild and transient. Only the platelet count decreased moderately. Clinical Relevance: Most of the hematological changes did not appear clinically relevant and resolved within 24 hours. However, the moderate decrease in platelet count could potentially predispose dogs undergoing IHD to an increased risk of bleeding.
- 1 June 2026
- Published by American Veterinary Medical Association (AVMA) in American Journal of Veterinary Research
- Vol. 87 (6)
Open AccessHematological changes after intermittent hemodialysis in dogs with acute kidney injury are mild and transient
Objective: To evaluate hematological changes in dogs with acute kidney injury caused by different underlying disease processes treated with intermittent hemodialysis (IHD) over 12 to 24 hours after the session. Methods: Client-owned dogs with acute kidney injury treated with IHD from February 2021 through July 2025 were prospectively enrolled in this observational study. Blood was collected from each dog before IHD (T0), after IHD (T1), and 12 to 24 hours after IHD (T2). Hematocrit, RBC count, hemoglobin concentration, reticulocyte count, platelet count, and WBC count were evaluated at all time points. Results: In total, 30 dogs with 82 IHD sessions were included in the study. Median RBC count (X 10 12 /L) and median hemoglobin concentration (mmol/L) decreased from 4.00 (2.82 to 7.22) and 9.25 (6.60 to 17.20) at T0 to 3.74 (2.39 to 7.04) and 9.00 (5.50 to 16.80) at T1, respectively. Median WBC count (X 10 9 /L) of 19.34 (6.49 to 55.47) at T0 decreased to 17.6 (4.57 to 73.22) at T1 and increased to 20.11 (7.48 to 55.47) at T2. Median platelet count (X 10 9 /L) of 99 (5 to 767) at T0 decreased to 69 (1 to 633) at T1 and increased to 84 (4 to 604) at T2. Conclusions: Hematological changes during IHD were mild and transient. Only the platelet count decreased moderately. Clinical Relevance: Most of the hematological changes did not appear clinically relevant and resolved within 24 hours. However, the moderate decrease in platelet count could potentially predispose dogs undergoing IHD to an increased risk of bleeding.
- Open Access
- 15 April 2026
- Published by Frontiers Media SA in Frontiers in Veterinary Science
- Vol. 13, 1790755
Diagnostic performance of lung ultrasound compared to thoracic radiography in non-traumatized dogs and cats with respiratory distress in an emergency setting
Introduction: Respiratory distress is a medical emergency requiring rapid diagnostic decision-making. This prospective observational study evaluated the efficiency and diagnostic performance of lung ultrasound (LUS) and thoracic radiography (TXR) in dogs and cats presenting with tachypnea. Imaging-based suspected diagnoses were compared with definitive diagnoses established by specialists using additional diagnostic procedures. The influence of observer experience on diagnostic accuracy was assessed. Methods: Client-owned animals with suspected intrathoracic causes of respiratory distress underwent both LUS and TXR within 24 h of presentation, with a maximum interval of 1 h between examinations. Imaging was performed according to standardized protocols. Based on imaging findings, the suspected cause of breathing difficulties was categorized as: no detectable intrathoracic cause, cardiac-related respiratory distress, pulmonary disease, neoplasia, or pleural effusion of unknown etiology. Following stabilization, patients were referred to specialists for establishment of the definitive diagnosis. Concordance between suspected and definitive diagnoses was analyzed separately for each modality to assess diagnostic performance. Selected cases were re-evaluated in a blinded fashion by observers with three different levels of experience. Results: A total of 144 animals (83 dogs and 61 cats) with acute respiratory distress were included. The suspected diagnosis based on LUS was concordant with the definitive diagnosis in 80.6% of cases, while TXR achieved 89.1%. Both modalities were correct in 77.5% of cases, and at least one modality was correct in 92.2%. Diagnostic accuracy of TXR was statistically significantly higher than that of LUS (absolute difference 8.5%). In dogs, the presence of a heart murmur was strongly associated with a cardiac cause of respiratory distress (odds ratio 10.9), whereas this association was not statistically significant in cats. In the blinded re-evaluation, TXR demonstrated higher interobserver agreement (Fleiss’ kappa = 0.69). The highest agreement was achieved by a less experienced observer, with a Cohen’s kappa of 0.8 for TXR. Conclusion: Both LUS and TXR are valuable imaging modalities for initial classification of respiratory distress, each offering specific advantages depending on the underlying pathology. In most cases, these techniques provide sufficient information to guide initial therapeutic decisions; however, a multimodal approach is recommended for complex presentations.
- 15 April 2026
- Published by Frontiers Media SA in Frontiers in Veterinary Science
- Vol. 13, 1790755
Open AccessDiagnostic performance of lung ultrasound compared to thoracic radiography in non-traumatized dogs and cats with respiratory distress in an emergency setting
Introduction: Respiratory distress is a medical emergency requiring rapid diagnostic decision-making. This prospective observational study evaluated the efficiency and diagnostic performance of lung ultrasound (LUS) and thoracic radiography (TXR) in dogs and cats presenting with tachypnea. Imaging-based suspected diagnoses were compared with definitive diagnoses established by specialists using additional diagnostic procedures. The influence of observer experience on diagnostic accuracy was assessed. Methods: Client-owned animals with suspected intrathoracic causes of respiratory distress underwent both LUS and TXR within 24 h of presentation, with a maximum interval of 1 h between examinations. Imaging was performed according to standardized protocols. Based on imaging findings, the suspected cause of breathing difficulties was categorized as: no detectable intrathoracic cause, cardiac-related respiratory distress, pulmonary disease, neoplasia, or pleural effusion of unknown etiology. Following stabilization, patients were referred to specialists for establishment of the definitive diagnosis. Concordance between suspected and definitive diagnoses was analyzed separately for each modality to assess diagnostic performance. Selected cases were re-evaluated in a blinded fashion by observers with three different levels of experience. Results: A total of 144 animals (83 dogs and 61 cats) with acute respiratory distress were included. The suspected diagnosis based on LUS was concordant with the definitive diagnosis in 80.6% of cases, while TXR achieved 89.1%. Both modalities were correct in 77.5% of cases, and at least one modality was correct in 92.2%. Diagnostic accuracy of TXR was statistically significantly higher than that of LUS (absolute difference 8.5%). In dogs, the presence of a heart murmur was strongly associated with a cardiac cause of respiratory distress (odds ratio 10.9), whereas this association was not statistically significant in cats. In the blinded re-evaluation, TXR demonstrated higher interobserver agreement (Fleiss’ kappa = 0.69). The highest agreement was achieved by a less experienced observer, with a Cohen’s kappa of 0.8 for TXR. Conclusion: Both LUS and TXR are valuable imaging modalities for initial classification of respiratory distress, each offering specific advantages depending on the underlying pathology. In most cases, these techniques provide sufficient information to guide initial therapeutic decisions; however, a multimodal approach is recommended for complex presentations.
- Open Access
- 13 October 2025
- Published by Frontiers Media SA in Frontiers in Veterinary Science
- Vol. 12, 1671034
Case Report: Management of a delayed type III hypersensitivity reaction with acute kidney injury in a dog after administration of human serum albumin with immunoadsorption
A six-year-old, intact male German Shepherd, weighing 43 kg, was presented with generalized edema formation and acute kidney injury due to a suspected delayed type III hypersensitivity reaction and vasculitis 2 weeks after the administration of human serum albumin (HSA). At presentation, the patient had a moderately reduced general condition, a heart rate of 96/min, rectal temperature of 37.0 °C, generalized edema, hematoma and petechiae on all limbs and the abdomen, and scleral hemorrhage. The initial blood work showed a moderate anemia, a severe azotemia, and a moderate hypoalbuminemia. Marked proteinuria with a urine protein-creatinine ratio (UPC) of 6.26 was present. The presence of anti-HSA antibodies was proven with an in-house ELISA. For treatment, immunoadsorption (IA) was performed with the TheraSorb® Ig Omni 1 adsorber, which was integrated in the LIFE 21® apheresis unit. Due to severe azotemia, an intermittent hemodialysis treatment with the dialysis platform Fresenius 4008 was performed after IA. Both treatments were repeated on the following day. A total plasma volume of 1.9 liters and 3.7 liters, respectively, was processed with IA. On the following days, creatinine concentration declined and the patient improved significantly. The patient was discharged after 10 days. UPC decreased to 0.82 and edema completely resolved. Two weeks after discharge, Creatinine, UPC and albumin were in the reference range. IA might be an additional therapeutic option for dogs with severe acute kidney injury due to a suspected delayed type III hypersensitivity reaction.
- 13 October 2025
- Published by Frontiers Media SA in Frontiers in Veterinary Science
- Vol. 12, 1671034
Open AccessCase Report: Management of a delayed type III hypersensitivity reaction with acute kidney injury in a dog after administration of human serum albumin with immunoadsorption
A six-year-old, intact male German Shepherd, weighing 43 kg, was presented with generalized edema formation and acute kidney injury due to a suspected delayed type III hypersensitivity reaction and vasculitis 2 weeks after the administration of human serum albumin (HSA). At presentation, the patient had a moderately reduced general condition, a heart rate of 96/min, rectal temperature of 37.0 °C, generalized edema, hematoma and petechiae on all limbs and the abdomen, and scleral hemorrhage. The initial blood work showed a moderate anemia, a severe azotemia, and a moderate hypoalbuminemia. Marked proteinuria with a urine protein-creatinine ratio (UPC) of 6.26 was present. The presence of anti-HSA antibodies was proven with an in-house ELISA. For treatment, immunoadsorption (IA) was performed with the TheraSorb® Ig Omni 1 adsorber, which was integrated in the LIFE 21® apheresis unit. Due to severe azotemia, an intermittent hemodialysis treatment with the dialysis platform Fresenius 4008 was performed after IA. Both treatments were repeated on the following day. A total plasma volume of 1.9 liters and 3.7 liters, respectively, was processed with IA. On the following days, creatinine concentration declined and the patient improved significantly. The patient was discharged after 10 days. UPC decreased to 0.82 and edema completely resolved. Two weeks after discharge, Creatinine, UPC and albumin were in the reference range. IA might be an additional therapeutic option for dogs with severe acute kidney injury due to a suspected delayed type III hypersensitivity reaction.
- Open Access
- 28 September 2025
- Published by SAGE Publications in Journal of Feline Medicine and Surgery
- Vol. 27 (9)
Evaluation of different doses of medetomidine for the induction of emesis in cats
Objectives: This study aimed to investigate the emetic effect of medetomidine, determine the best dose for clinical practice and investigate any adverse effects at different doses. Methods: In this prospective, observational study, 10, 20, 30 and 40 µg/kg of medetomidine was administered intramuscularly (IM) to cats after ingestion of foreign substances, to induce emesis. The success rate, frequency, time after injection, sedation score and adverse effects were recorded. If induction of emesis was not successful after 10 or 20 µg/kg medetomidine, a second bolus of medetomidine (20 µg/kg IM) was administered 10 mins later. Results: A total of 58 cats were included after foreign material ingestion. Emesis was achieved with all doses of medetomidine (39/58), whereby the highest success rate was reached with 20 µg/kg (13/17). The success rate after the first injection was not statistically different between the different medetomidine doses ( P = 0.457). The median time to emesis after the first injection of medetomidine for all cats was 5 mins (range 3–14). The sedation score was lower after 10 µg/kg medetomidine compared with 40 µg/kg ( P = 0.013). The most common adverse effect was sedation. Medetomidine was antagonised with atipamezole in 47/58 cats. Conclusions and relevance: Medetomidine is an effective drug for inducing emesis in cats and is a reasonable alternative to other alpha 2 -agonists. The most successful dose with the least adverse effects was 20 µg/kg IM.
- 28 September 2025
- Published by SAGE Publications in Journal of Feline Medicine and Surgery
- Vol. 27 (9)
Open AccessEvaluation of different doses of medetomidine for the induction of emesis in cats
Objectives: This study aimed to investigate the emetic effect of medetomidine, determine the best dose for clinical practice and investigate any adverse effects at different doses. Methods: In this prospective, observational study, 10, 20, 30 and 40 µg/kg of medetomidine was administered intramuscularly (IM) to cats after ingestion of foreign substances, to induce emesis. The success rate, frequency, time after injection, sedation score and adverse effects were recorded. If induction of emesis was not successful after 10 or 20 µg/kg medetomidine, a second bolus of medetomidine (20 µg/kg IM) was administered 10 mins later. Results: A total of 58 cats were included after foreign material ingestion. Emesis was achieved with all doses of medetomidine (39/58), whereby the highest success rate was reached with 20 µg/kg (13/17). The success rate after the first injection was not statistically different between the different medetomidine doses ( P = 0.457). The median time to emesis after the first injection of medetomidine for all cats was 5 mins (range 3–14). The sedation score was lower after 10 µg/kg medetomidine compared with 40 µg/kg ( P = 0.013). The most common adverse effect was sedation. Medetomidine was antagonised with atipamezole in 47/58 cats. Conclusions and relevance: Medetomidine is an effective drug for inducing emesis in cats and is a reasonable alternative to other alpha 2 -agonists. The most successful dose with the least adverse effects was 20 µg/kg IM.
- 1 August 2025
- Published by Georg Thieme Verlag KG in Tierärztliche Praxis Ausgabe K: Kleintiere / Heimtiere
- Vol. 53 (04) , 248-255
Überwachung labordiagnostischer Parameter bei Intensivpatienten – Teil 1
Zusammenfassung: Kritisch kranke Hunde und Katzen zeigen häufig komplexe Veränderungen mehrerer Organsysteme sowie systemische Entzündungsreaktionen und Infektionen. Eine strukturierte Herangehensweise an die Diagnostik dieser Patienten ist essenziell, um relevante Abweichungen frühzeitig zu erkennen und gezielt therapieren zu können. Ein etabliertes Hilfsmittel hierfür stellt das sogenannte „Rule of 20“-Schema dar, das eine systematische Erfassung zentraler klinischer und labordiagnostischer Parameter ermöglicht. Ziel des vorliegenden Übersichtsartikels ist es, einen praxisorientierten Überblick über die wichtigsten labordiagnostischen Tests sowie deren häufigsten Befunde bei kritisch kranken Hunden und Katzen zu geben.Teil 1 dieses zweiteiligen Übersichtsartikels befasst sich mit zentralen hämatologischen Parametern bei intensivmedizinisch betreuten Kleintierpatienten. Im Fokus stehen Hämatokrit, Leukozyten- und Thrombozytenzahl sowie häufige Veränderungen wie Anämie, Polyzythämie, Leukozytose und Thrombozytopenie. Zudem werden Störungen der Hämostase im Sinne einer Hypo- oder Hyperkoagulabilität diskutiert. Zur Diagnostik systemischer Entzündungsreaktionen sowie Infektionen werden die Bedeutung von Akute-Phase-Proteinen und mikrobiologischer Untersuchungen dargestellt. Zudem werden myokardiale Marker als Hinweis auf infektiöse Myokardschäden, wie sie bei Sepsis auftreten können besprochen.
- 1 August 2025
- Published by Georg Thieme Verlag KG in Tierärztliche Praxis Ausgabe K: Kleintiere / Heimtiere
- Vol. 53 (04) , 248-255
Überwachung labordiagnostischer Parameter bei Intensivpatienten – Teil 1
Zusammenfassung: Kritisch kranke Hunde und Katzen zeigen häufig komplexe Veränderungen mehrerer Organsysteme sowie systemische Entzündungsreaktionen und Infektionen. Eine strukturierte Herangehensweise an die Diagnostik dieser Patienten ist essenziell, um relevante Abweichungen frühzeitig zu erkennen und gezielt therapieren zu können. Ein etabliertes Hilfsmittel hierfür stellt das sogenannte „Rule of 20“-Schema dar, das eine systematische Erfassung zentraler klinischer und labordiagnostischer Parameter ermöglicht. Ziel des vorliegenden Übersichtsartikels ist es, einen praxisorientierten Überblick über die wichtigsten labordiagnostischen Tests sowie deren häufigsten Befunde bei kritisch kranken Hunden und Katzen zu geben.Teil 1 dieses zweiteiligen Übersichtsartikels befasst sich mit zentralen hämatologischen Parametern bei intensivmedizinisch betreuten Kleintierpatienten. Im Fokus stehen Hämatokrit, Leukozyten- und Thrombozytenzahl sowie häufige Veränderungen wie Anämie, Polyzythämie, Leukozytose und Thrombozytopenie. Zudem werden Störungen der Hämostase im Sinne einer Hypo- oder Hyperkoagulabilität diskutiert. Zur Diagnostik systemischer Entzündungsreaktionen sowie Infektionen werden die Bedeutung von Akute-Phase-Proteinen und mikrobiologischer Untersuchungen dargestellt. Zudem werden myokardiale Marker als Hinweis auf infektiöse Myokardschäden, wie sie bei Sepsis auftreten können besprochen.
- Open Access
- 28 July 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (7) , e0328306
Pilot study: In vitro reduction of hemoglobin from canine blood with hemoperfusion using the Cytosorb® adsorber
Cell-free hemoglobin (cfHb) can be toxic and lead to kidney injury. This study assessed the in vitro reduction of cfHb from canine hemolyzed blood using hemoperfusion with a Cytosorb® cytokine adsorber. Canine whole blood was processed in linear and circular setups, with three runs each, at 100 mL/min. Hemolysis and osmolarity adjustments were performed with distilled water and hypertonic saline. Anticoagulation was optimized with heparin (10,000 IU/L). A median of 3.38 L of hemoglobin solution was processed in the linear setup. Samples were collected after the adsorber and from the waste bag. In the circular setup, a median of 2.09 L was processed, with samples taken before and after the adsorber. CfHb concentration was measured using the XT-2000iV® hematology analyzer (Sysmex). A control setup without an adsorber was run for 24 hours to assess cfHb stability. In the linear setup, cfHb concentration decreased by a median of 17.8% (14.7–26.8%), from 1.7 mmol/L to a minimum of 0.9 mmol/L, with 12.1 g (11.9–23.5 g) of cfHb removed. The median cfHb concentration after the adsorber displayed a logarithmic increase from 0.9 mmol/L (0.8–1.2 mmol/L) to 1.6 mmol/L (1.4–2.1 mmol/L). After processing 2.4 L, no further reduction occurred. In the circular setup, cfHb was reduced by a median of 41.3% (46.1–45.0%), representing 17.4 g (14.6–19.0 g) removed after 13.0 L (13.0–14.0 L). The reduction plateau was reached after 13 L. The hemoglobin reduction ratio in the circular setup at 3 L processed cfHb-solution was 25.0% (23.1–33.3%) and was not different from the linear setup (p = 0.400). The cfHb clearance decreased in both setups over time. CfHb concentration in the control setup was stable for 24 hours. Hemoperfusion with the Cytosorb® adsorber reduced cfHb in vitro from a canine blood solution.
- 28 July 2025
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 20 (7) , e0328306
Open AccessPilot study: In vitro reduction of hemoglobin from canine blood with hemoperfusion using the Cytosorb® adsorber
Cell-free hemoglobin (cfHb) can be toxic and lead to kidney injury. This study assessed the in vitro reduction of cfHb from canine hemolyzed blood using hemoperfusion with a Cytosorb® cytokine adsorber. Canine whole blood was processed in linear and circular setups, with three runs each, at 100 mL/min. Hemolysis and osmolarity adjustments were performed with distilled water and hypertonic saline. Anticoagulation was optimized with heparin (10,000 IU/L). A median of 3.38 L of hemoglobin solution was processed in the linear setup. Samples were collected after the adsorber and from the waste bag. In the circular setup, a median of 2.09 L was processed, with samples taken before and after the adsorber. CfHb concentration was measured using the XT-2000iV® hematology analyzer (Sysmex). A control setup without an adsorber was run for 24 hours to assess cfHb stability. In the linear setup, cfHb concentration decreased by a median of 17.8% (14.7–26.8%), from 1.7 mmol/L to a minimum of 0.9 mmol/L, with 12.1 g (11.9–23.5 g) of cfHb removed. The median cfHb concentration after the adsorber displayed a logarithmic increase from 0.9 mmol/L (0.8–1.2 mmol/L) to 1.6 mmol/L (1.4–2.1 mmol/L). After processing 2.4 L, no further reduction occurred. In the circular setup, cfHb was reduced by a median of 41.3% (46.1–45.0%), representing 17.4 g (14.6–19.0 g) removed after 13.0 L (13.0–14.0 L). The reduction plateau was reached after 13 L. The hemoglobin reduction ratio in the circular setup at 3 L processed cfHb-solution was 25.0% (23.1–33.3%) and was not different from the linear setup (p = 0.400). The cfHb clearance decreased in both setups over time. CfHb concentration in the control setup was stable for 24 hours. Hemoperfusion with the Cytosorb® adsorber reduced cfHb in vitro from a canine blood solution.
- Open Access
Supportive Treatment of a Dog with Leishmaniosis and Severe Glomerulopathy with Immunoadsorption
A three-year-old, intact female mix-breed dog, weighing 30 kg, was presented due to vomitus and diarrhea. At presentation, the patient had a slightly reduced general condition and moderately enlarged mandibular and popliteal lymph nodes. The initial blood work showed severe azotemia and hypoalbuminemia. In the urinalysis, marked proteinuria with a urine protein/creatinine ratio (UPC) of 4.69 was found. Further workup showed a high leishmania antibody titer. The dog was diagnosed with leishmaniosis and glomerulonephritis. Initial treatment consisted of intravenous fluid therapy, allopurinol, miltefosine, amlodipine, clopidogrel, and a diet with a low purine content. Creatinine temporarily decreased but increased again after three days. For further supportive treatment, intermittent hemodialysis in combination with hemoperfusion with the cytosorb® adsorber was performed. A total blood volume of 17.7 L was processed within three hours. Thereafter, immunoadsorption (IA) was performed with the COM.TEC® and ADAsorb® platforms and a LIGASORB® adsorber to eliminate circulating immunocomplexes. Treatment time for IA was two hours with a blood flow of 50 mL/min. A total plasma volume of 2.4 L was processed. Over the following days, creatinine declined, and the patient improved significantly. UPC decreased to 1.74 on day 17 after IA. The patient was discharged after two and a half weeks. Two years after the initial event, the patient is still in excellent condition, with creatinine, UPC, and albumin levels in the reference range. Therefore, IA might be an additional therapeutic option for dogs with leishmaniosis-induced glomerulonephritis and subsequent severe azotemia to improve immunocomplex-mediated glomerulonephritis.
Open AccessSupportive Treatment of a Dog with Leishmaniosis and Severe Glomerulopathy with Immunoadsorption
A three-year-old, intact female mix-breed dog, weighing 30 kg, was presented due to vomitus and diarrhea. At presentation, the patient had a slightly reduced general condition and moderately enlarged mandibular and popliteal lymph nodes. The initial blood work showed severe azotemia and hypoalbuminemia. In the urinalysis, marked proteinuria with a urine protein/creatinine ratio (UPC) of 4.69 was found. Further workup showed a high leishmania antibody titer. The dog was diagnosed with leishmaniosis and glomerulonephritis. Initial treatment consisted of intravenous fluid therapy, allopurinol, miltefosine, amlodipine, clopidogrel, and a diet with a low purine content. Creatinine temporarily decreased but increased again after three days. For further supportive treatment, intermittent hemodialysis in combination with hemoperfusion with the cytosorb® adsorber was performed. A total blood volume of 17.7 L was processed within three hours. Thereafter, immunoadsorption (IA) was performed with the COM.TEC® and ADAsorb® platforms and a LIGASORB® adsorber to eliminate circulating immunocomplexes. Treatment time for IA was two hours with a blood flow of 50 mL/min. A total plasma volume of 2.4 L was processed. Over the following days, creatinine declined, and the patient improved significantly. UPC decreased to 1.74 on day 17 after IA. The patient was discharged after two and a half weeks. Two years after the initial event, the patient is still in excellent condition, with creatinine, UPC, and albumin levels in the reference range. Therefore, IA might be an additional therapeutic option for dogs with leishmaniosis-induced glomerulonephritis and subsequent severe azotemia to improve immunocomplex-mediated glomerulonephritis.
- Open Access
Successful Emergency Management of a Dog with Ventilator-Dependent Acquired Myasthenia Gravis with Immunoadsorption
A one-year-old, female intact Samoyed, 12.5 kg, was presented with coughing for 2 weeks, progressive appendicular and axial muscle weakness, megaesophagus and labored breathing for 5 days. There was no improvement with standard treatment. Acquired myasthenia gravis was suspected and the dog was referred with increasing dyspnea. At presentation, the dog showed a severely reduced general condition, was non-ambulatory and showed abdominal and severely labored breathing. A marked hypercapnia (PvCO2 = 90.1 mmHg) was present in venous blood gas analysis. The serum anti-acetylcholine receptor antibody test was consistent with acquired myasthenia gravis (2.1 nmol/L). The dog was anesthetized with propofol and mechanically ventilated with a Hamilton C1 ventilator. Immunoadsorption was performed with the COM.TEC® and ADAsorb® platforms and a LIGASORB® adsorber to eliminate anti-acetylcholine receptor antibodies. Local anticoagulation was performed with citrate. Treatment time for immunoadsorption was 1.5 h with a blood flow of 50 mL/min. A total plasma volume of 1.2 L was processed. Further medical treatment included intravenous fluid therapy, maropitant, esomeprazole, antibiotic therapy for aspiration pneumonia and neostigmine 0.04 mg/kg intramuscularly every 6 h for treatment of acquired myasthenia gravis. Mechanical ventilation was stopped after 12 h. A percutaneous gastric feeding tube was inserted under endoscopic control on day 2 for further medical treatment and nutrition. A second treatment with immunoadsorption was performed on day 3. Again, a total plasma volume of 1.2 L was processed. Immediately after this procedure, the dog regained muscle strength and was able to stand and to walk. After 6 days, the dog was discharged from the hospital. This is the first report of immunoadsorption for emergency management of a dog with acute-fulminant acquired myasthenia gravis. Immunoadsorption may be an additional option for emergency treatment in dogs with severe signs of acquired myasthenia gravis.
Open AccessSuccessful Emergency Management of a Dog with Ventilator-Dependent Acquired Myasthenia Gravis with Immunoadsorption
A one-year-old, female intact Samoyed, 12.5 kg, was presented with coughing for 2 weeks, progressive appendicular and axial muscle weakness, megaesophagus and labored breathing for 5 days. There was no improvement with standard treatment. Acquired myasthenia gravis was suspected and the dog was referred with increasing dyspnea. At presentation, the dog showed a severely reduced general condition, was non-ambulatory and showed abdominal and severely labored breathing. A marked hypercapnia (PvCO2 = 90.1 mmHg) was present in venous blood gas analysis. The serum anti-acetylcholine receptor antibody test was consistent with acquired myasthenia gravis (2.1 nmol/L). The dog was anesthetized with propofol and mechanically ventilated with a Hamilton C1 ventilator. Immunoadsorption was performed with the COM.TEC® and ADAsorb® platforms and a LIGASORB® adsorber to eliminate anti-acetylcholine receptor antibodies. Local anticoagulation was performed with citrate. Treatment time for immunoadsorption was 1.5 h with a blood flow of 50 mL/min. A total plasma volume of 1.2 L was processed. Further medical treatment included intravenous fluid therapy, maropitant, esomeprazole, antibiotic therapy for aspiration pneumonia and neostigmine 0.04 mg/kg intramuscularly every 6 h for treatment of acquired myasthenia gravis. Mechanical ventilation was stopped after 12 h. A percutaneous gastric feeding tube was inserted under endoscopic control on day 2 for further medical treatment and nutrition. A second treatment with immunoadsorption was performed on day 3. Again, a total plasma volume of 1.2 L was processed. Immediately after this procedure, the dog regained muscle strength and was able to stand and to walk. After 6 days, the dog was discharged from the hospital. This is the first report of immunoadsorption for emergency management of a dog with acute-fulminant acquired myasthenia gravis. Immunoadsorption may be an additional option for emergency treatment in dogs with severe signs of acquired myasthenia gravis.
- Open Access
- 11 January 2023
- Published by Frontiers Media SA in Frontiers in Veterinary Science
- Vol. 9, 1019700
C-reactive protein as a tool for monitoring response to treatment in dogs with acute hemorrhagic diarrhea syndrome
Objectives: C-reactive protein (CRP) is an established marker for systemic inflammation in dogs that is especially elevated in dogs with sepsis. Some dogs with acute hemorrhagic diarrhea syndrome (AHDS) develop bacterial translocation and consequent sepsis during hospitalization. This study aimed to evaluate the course of CRP plasma concentrations during hospitalization and its correlation with clinical and other laboratory variables in dogs with AHDS.Methods: In this prospective, observational study, CRP was evaluated on days 0, 1, 2, and 3 in 27 client-owned dogs who presented with AHDS. Clinical examination data, blood pressure, acute patient physiologic and laboratory evaluation (APPLE) full and APPLE fast scores, and canine hemorrhagic diarrhea severity (CHDS) index were measured on the same days to evaluate the severity of the disease.Results: Twenty-five of the 27 dogs were discharged from hospital. Nineteen dogs received antimicrobial treatment due to sepsis or neutropenia. CRP values were mildly elevated on day 0 (median 27.3 mg/L; 1.0–125.8 mg/L) and markedly elevated on day 1 (median 88.9 mg/L; 1.4–192.7 mg/L). CRP concentrations decreased gradually over the following days. Moreover, CRP concentrations correlated moderately with albumin, leucocyte count, neutrophil count, and APPLE full and fast scores, but not with antimicrobial treatment.Conclusion and relevance: CRP concentrations were significantly elevated in patients with AHDS. In this study population, CRP did not help in detecting the requirement of antimicrobial treatment in dogs with AHDS. Nevertheless, as CRP can monitor the response to treatment, regular analysis can guide treatment.
- 11 January 2023
- Published by Frontiers Media SA in Frontiers in Veterinary Science
- Vol. 9, 1019700
Open AccessC-reactive protein as a tool for monitoring response to treatment in dogs with acute hemorrhagic diarrhea syndrome
Objectives: C-reactive protein (CRP) is an established marker for systemic inflammation in dogs that is especially elevated in dogs with sepsis. Some dogs with acute hemorrhagic diarrhea syndrome (AHDS) develop bacterial translocation and consequent sepsis during hospitalization. This study aimed to evaluate the course of CRP plasma concentrations during hospitalization and its correlation with clinical and other laboratory variables in dogs with AHDS.Methods: In this prospective, observational study, CRP was evaluated on days 0, 1, 2, and 3 in 27 client-owned dogs who presented with AHDS. Clinical examination data, blood pressure, acute patient physiologic and laboratory evaluation (APPLE) full and APPLE fast scores, and canine hemorrhagic diarrhea severity (CHDS) index were measured on the same days to evaluate the severity of the disease.Results: Twenty-five of the 27 dogs were discharged from hospital. Nineteen dogs received antimicrobial treatment due to sepsis or neutropenia. CRP values were mildly elevated on day 0 (median 27.3 mg/L; 1.0–125.8 mg/L) and markedly elevated on day 1 (median 88.9 mg/L; 1.4–192.7 mg/L). CRP concentrations decreased gradually over the following days. Moreover, CRP concentrations correlated moderately with albumin, leucocyte count, neutrophil count, and APPLE full and fast scores, but not with antimicrobial treatment.Conclusion and relevance: CRP concentrations were significantly elevated in patients with AHDS. In this study population, CRP did not help in detecting the requirement of antimicrobial treatment in dogs with AHDS. Nevertheless, as CRP can monitor the response to treatment, regular analysis can guide treatment.